FATE
Fate Therapeutics, Inc. · Healthcare
Redmile Group, LLC bought $28.0M of Fate Therapeutics, Inc.
Director and 10% owner
Bought$27,999,968
$85.50Price
327,485Shares
+3%Stake
What FATE did for a copier
Prices for FATE after this filing aren't in yet.
Redmile Group, LLC's record
11 other buys with 3 months of prices since 2016: on average −16.3% against the S&P 500, and 3 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Jan 8. Filed Tue, Jan 12, 4:16 PM ET, after the close. Not investment advice.